If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
Click here to subscribe to our Magazine
World Courier
Latest Press Releases
In Conversation : Jean-Marie Aulnette, Vice President of EMEA sales, TraceLink on Serialization And Traceability

Professional LAB Marketplace for Asia Thailand LAB INTERNATIONAL 2018

The 8thInternational Trade Exhibition and Conference on Analytical Laboratory Equipment & Technology, Biotechnology & Life Sciences and Chemical & Safety will return again during 12th 14th September 2018 at EH102-103, BITEC, Thailand.


Solving the Patient Recruitment Dilemma

Lonza to Host New Webinar: "Engineering Culture Platforms to Mimic Liver Diseases"

On 16 May 2018, Lonza is hosting a free 60-minute webinar on innovative technologies for building advanced human liver culture platforms that better mimic common liver diseases, such as non-alcoholic fatty liver disease, liver fibrosis and hepatitis B...

Latest News
Introducing SMi's 6thannual conference on Pharmaceutical Freeze Drying Technologythis June 2018

Medigene AG: Medigene's Academic Partners Provide Update on Planned MAGE-A1-specific TCR Clinical IIT during CIMT

Planegg Medigene AG announced that researchers from Max-Delbruck-Center for Molecular Medicine and Charite, both in Berlin, Germany, will present an update on the clinical trial preparations concerning a MAGE-A1-specific T cell receptor...


CEVEC and CSL Limited sign exclusive license agreement for production of recombinant C1 Esterase Inhibitor using CEVEC's CAP technology

CEVEC an CSL Limited announced an exclusive licensing agreement for the development, manufacture and commercialization of recombinant C1 Esterase Inhibitor (C1-INH) proteins for Hereditary Angioedema...



WuXi STA Changzhou Site Passes First U.S. FDA Inspection

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, announces that its active pharmaceutical ingredient R&D and manufacturing facility located in Changzhou, China has secured Pre-Approval Inspection for two APIs from the U.S. FDA with no Form 483s issued.


For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com

World Pharma Today